Published on in Vol 7 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/49965, first published
.
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial
Journals
- Niyangoda D, Muayad M, Tesfaye W, Bushell M, Ahmad D, Samarawickrema I, Sinclair J, Kebriti S, Maida V, Thomas J. Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence. Pharmaceutics 2024;16(8):1081 View
- Niyangoda D, Aung M, Qader M, Tesfaye W, Bushell M, Chiong F, Tsai D, Ahmad D, Samarawickrema I, Sinnollareddy M, Thomas J. Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus. Antibiotics 2024;13(11):1023 View
- Rusu A, Farcaș A, Oancea O, Tanase C. Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science. Biomolecules 2025;15(9):1219 View
- Candeloro B, de Oliveira C, Gimenez F, Barbosa M, Soares B, Ruiz A, Folegatti D, Barbalho S, Oliveira N, Porto A, Garner D, Sousa F, Valenti V. The Pleiotropic Influence of Cannabidiol and Tetrahydrocannabinol on Inflammatory Biomarkers: A Systematic Review and Meta-Analytical Synthesis. International Journal of Molecular Sciences 2025;26(23):11618 View
Books/Policy Documents
- Szejko N, Saramak K, Müller-Vahl K. Behavioral Impact of Cannabinoids. View